Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: Results from a cluster randomized control trial

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Dicko, Alassane ^a   Toure, Sidy ^a   Traore, Mariam ^a   Sagara, Issaka ^a   Toure, Ousmane ^a   Sissoko, Mahamadou ^a   Diallo, Alpha ^b   Rogier, Christophe ^c   Salomon, Roger ^d   De Sousa, Alexandra ^e   Doumbo, Ogobara ^a  

^a UNIVERSITY OF BAMAKO   (Mali)

^b UNICEF   (United States)

^c INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

expanded program of immunization; intermittent preventive treatment; malaria; sulphadoxine pyrimethamine

Indexed keywords

ANTIMALARIAL AGENT; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE; VACCINE;

ARTICLE; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG COMBINATION; FEMALE; HUMAN; INFANT; MALARIA; MALE; MALI; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL;

ANTIMALARIALS; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; DRUG COMBINATIONS; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALARIA; MALE; MALI; PYRIMETHAMINE; SULFADOXINE; VACCINES;

EID: 79960560684     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-573     Document Type: Article

References (38)

1. IPTi Consortium. Intermittent preventive treatment for malaria control in infants: moving towards evidence-based policy and public health action. Egan A Crawley J Schellenberg D,, Trop Med Int Health 2005 10 9 815 7 10.1111/j.1365-3156.2005.01474.x 16135186 (Pubitemid 41291219)
2. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Aponte JJ Schellenberg D Egan A, et al. Lancet 2009 374 9700 1533 42 10.1016/S0140-6736(09)61258-7 19765816
3. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial. Gosling RD Gesase S Mosha JF, et al. Lancet 2009 374 9700 1521 32 10.1016/S0140-6736(09)60997-1 19765815
4. Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania. Hutton G Schellenberg D Tediosi F, et al. Bull World Health Organ 2009 87 2 123 9 10.2471/BLT.08.051961 19274364
5. The acceptability of intermittent preventive treatmentof malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania. Pool R Mushi A, Schellenberg JA Mrisho M,, et al. Malar J 2008 7 213 18939971
6. Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settings. Gysels M Pell C Mathanga DP,,, et al. Malar J 2009 8 191 10.1186/1475-2875-8-191 19664250
7. The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa. Conteh L Sicuri E Manzi F,,, et al. PLoS One 2010 5 6 10313 10.1371/journal.pone.0010313 20559558
8. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Schellenberg D Menendez C Kahigwa E,,, et al. Lancet 2001 357 1471 7 10.1016/S0140-6736(00)04643-2 11377597
9. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo- controlled trial. Macete E Aide P Aponte JJ,,, et al. J Infect Dis 2006 194 276 85 10.1086/505431 16826474 (Pubitemid 44116968)
10. Interim report on IPTi with SP. World Health Organisation, WHO Advisory Committee on Serological responses to EPI vaccines in Infants receiving IPTi. (Internal Report) 2006
11. Intermittent preventive treatment in infants - adjusting expectations and seeing opportunity. ter Kuile FO Steketee RW, J Infect Dis 2006 194 3 269 72 10.1086/505434 16826472 (Pubitemid 44116966)
12. Pharmacovigilance of malaria Intermittent Preventive Treatment in infants coupled with routine immunizations in six African countries. de Sousa A Rabarijaona LP Tenkorang O, et al. J Infect Dis
13. WHO Policy recommendation on Intermittent Preventive Treatment during infancy with sulphadoxine pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa. http://www.who.int/malaria/news/WHO-policy- recommendation-IPTi-032010.pdf
14. Review of intermittent preventive treatment for malaria in infants and children. Munday S, J Paediatr Child Health 2007 43 6 424 8 10.1111/j.1440-1754. 2007.01105.x 17535170 (Pubitemid 46802255)
15. Acceptability of coupling Intermittent Preventive Treatment in infants with the Expanded Program on Immunization in three francophone countries in Africa. de Sousa A Rabarijaona LP Ndiaye JL,,, et al. Trop Med Int Health
16. Annuaire Système Local d'Information Sanitaire (SLIS) 2006. Ministère de la SantéRépublique du Mali, DNS - N'Tominkorobougou 2007 http://www.sante.gov.ml/docs/pdf/slis2007.pdf 21601037
17. Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali. Coulibaly D Diallo DA Thera MA,,, et al. Am J Trop Med Hyg 2002 67 6 604 10 12518850 (Pubitemid 36014916)
18. Year-to-year variation in the age-specific incidence of clinical malaria in two potential vaccine testing sites in Mali with different levels of malaria transmission intensity. Dicko A Sagara I Diemert D,,, et al. Am J Trop Med Hyg 2007 77 6 1028 33 18165516 (Pubitemid 351837787)
19. Impact of intermittent preventive treatment with sulphadoxine- pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali. Dicko A Sagara I Sissoko MS,,, et al. Malar J 2008 7 123 10.1186/1475-2875-7-123 18611271
20. Efficacy of chloroquine, amodiaquine and sulphadoxine pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali. Tekete M Djimdé AA Beavogui AH,,, et al. Malar J 2009 8 34 10.1186/1475-2875-8-34 19245687
21. Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali. Dicko A Sagara I Djimdé AA,,, et al. Malar J 2010 9 9 10.1186/1475-2875-9-9 20064223
22. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial. Dicko A Diallo AI Tembine I,,, et al. PLoS Med 2011 8 2 1000407 10.1371/journal.pmed.1000407 21304923
23. Enquête Démographique et de Santé (EDSM-III), Mali. http://www.malikunnafoni.com/bibliostat/docs/149102020-cps-ms-2002.pdf
24. Enquête Démographique et de Santé (EDSM-IV), Mali. http://www.malariafreefuture.org/projects/mali/docs/dhs.pdf
25. WHO Immunization coverage cluster survey reference manual. http://www.who.int/vaccines-documents/DocsPDF05/www767.pdf
26. Determinants of vaccination coverage in rural Nigeria. Odusanya OO Alufohai EF, Meurice FP Ahonkhai VI, BMC Public Health 2008 8 381 10.1186/1471-2458-8-381 18986544
27. Mother's knowledge about vaccine preventable diseases and immunization coverage in a population with high rate of illiteracy. Rahman M Islam MA Mahalanabis D, J Trop Pediatr 1995 41 376 8 8606451 (Pubitemid 26020174)
28. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. Chandramohan D Owusu-Agyei S Carneiro I, et al. BMJ 2005 331 727 33 10.1136/bmj.331.7519.727 16195288 (Pubitemid 41414939)
29. World health report 2006: working together for health. World Health Organization, Geneva
30. Intermittent preventive treatment for malaria and anaemia control in Tanzanian infants; the development and implementation of a public health stratetegy. Manzi F Schellenberg J Hamis Y,,, et al. Trans R Soc Trop Med Hyg 2009 103 1 79 86 10.1016/j.trstmh.2008.08.014 18823639
31. Implementing intermittent preventive treatment in infants. de Sousa A Salama P Chopra M, Lancet 2010 375 9709 121 20109889
32. State of the World's Vaccines and Immunization 2002. World Health Organization, World Health Organization; Geneva 2002
33. Is the Expanded Programme on Immunisation the most appropriate delivery system for intermittent preventive treatment of malaria in West Africa? Chandramohan D Webster J, Smith L Awine T, Owusu-Agyei S Carneiro I, Trop Med Int Health 2007 12 6 743 50 10.1111/j.1365-3156.2007.01844.x 17550471 (Pubitemid 46872791)
34. Assessment of the Role of Intermittent Preventive Treatment for Malaria in Infants. Institute of Medicine, Letter Report http://www.iom.edu/Reports/ 2008/Assessment-of-the-Role-of-Intermittent-Preventive-Treatment-for-Malaria-in- Infants-Letter-Report.aspx
35. Report of the Technical Expert Group (TEG) Meeting on Intermittent Preventive Therapy in Infancy (IPTi) Geneva 8-10 October 2007 http://www.who.int/malaria/publications/atoz/tegconsultiptioct2007report.pdf
36. Report of the Technical Expert Group (TEG) Technical Consultation on Intermittent Preventive Treatment in Infants (IPTi), Technical Expert Group on Preventive Chemotherapy, 23-24 April 2009 - WHO\HQ, Geneva, Switzerland http://www.who.int/malaria/publications/atoz/tegconsultiptiapr2009report.pdf
37. Evaluation of immunization coverage within the Expanded Program on Immunization in Kita Circle, Mali: a cross-sectional survey. Koumaré AK Traore D Haidara F, et al. BMC Int Health Hum Rights 2009 9 Suppl 1 13 10.1186/1472-698X-9-S1-S13 19828057
38. Meeting of the Strategic Advisory Group of Experts on immunization, October 2009 - conclusions and recommendations. World Health Organization, Weekly epidemiological record 2009 84 50 517 532 http://www.who.int/wer/2009/ wer8450.pdf 19999831